Skip to content
Screener

Septerna, Inc. SEPN Return on invested capital

Return on invested capital at other companies

Amgen logo
AmgenAMGN
14.8%+3.6pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-114.4%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-52.1%+9.1pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-89.5%+48.4pp
Schrodinger logo
SchrodingerSDGR
-83.1%+94.1pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759

FAQ

What is Septerna, Inc.'s return on invested capital?
Septerna, Inc. (SEPN) reported return on invested capital of -27.8% in Q4 2025.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about Septerna, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude